Inicio › Cáncer de pulmón › Míchigan › Lansing
Ensayos clínicos de Cáncer de pulmón en Lansing, MI
11 estudios para Cáncer de pulmón buscan participantes en centros de Lansing y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- University of Michigan Health - Sparrow Lansing, Lansing
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
ReclutandoFase 3
- University of Michigan Health - Sparrow Lansing, Lansing
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ReclutandoFase 3
- University of Michigan Health - Sparrow Lansing, Lansing
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ReclutandoFase 3
- University of Michigan Health - Sparrow Lansing, Lansing
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- University of Michigan Health - Sparrow Lansing, Lansing
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ReclutandoFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
- University of Michigan Health - Sparrow Lansing, Lansing
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
ReclutandoFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- University of Michigan Health - Sparrow Lansing, Lansing
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- University of Michigan Health - Sparrow Lansing, Lansing
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- University of Michigan Health - Sparrow Lansing, Lansing
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Lansing
Más información sobre Cáncer de pulmón en MedlinePlus
Ensayos de Cáncer de pulmón en otras ciudades
- Houston, TX78 estudios
- Boston, MA62 estudios
- New York City, NY60 estudios
- Los Angeles, CA45 estudios
- Washington, DC41 estudios
- Chicago, IL41 estudios
- Nashville, TN40 estudios
- Arlington, VA40 estudios
- Baltimore, MD40 estudios
- St. Louis, MO39 estudios
- Columbus, OH36 estudios
- Philadelphia, PA36 estudios
Otros estudios en Lansing
- Cáncer de seno10 estudios
- Cáncer de próstata10 estudios
- Cáncer de pulmón de células no pequeñas9 estudios
- Cáncer (todos los tipos)7 estudios
- Trastornos de somnolencia excesiva5 estudios
- Cáncer de laringe5 estudios
- Cáncer de vejiga5 estudios
- Problemas del sueño4 estudios
- Cáncer del colon y del recto4 estudios
- Carcinoma de células escamosas de cabeza y cuello4 estudios
- Cáncer hipofaríngeo4 estudios
- Cáncer oral4 estudios
De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.